Morgan Stanley raised the firm’s price target on Ventas to $47 from $45 and keeps an Equal Weight rating on the shares. Senior housing demand is recovering ahead of expectations and the firm sees “another potential leg of outperformance,” says the analyst, who adds that Ventas’s valuation “looks attractive.” However, the stock remains a show me story and the firm is taking “a wait and see approach on execution,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VTR: